AffaMed Therapeutics
Wicks Chung is a seasoned professional in the biopharmaceutical and ophthalmic sectors, currently serving as the Commercial Director for Ophthalmology at AffaMed Therapeutics since November 2021. In this role, Wicks is responsible for the strategic planning and commercialization of ophthalmic products in the Asia region. Prior to AffaMed, Wicks held the position of Associate Director, Commercial at CSL Behring Asia Pacific Limited from October 2013 to June 2020, where responsibilities included developing commercial strategies across several South Asian markets. Wicks also has extensive experience from Bausch & Lomb (HK) Ltd. as Senior Marketing & Business Development Manager from May 2003 to April 2012, focusing on marketing strategies for ophthalmic pharmaceuticals, and from Pharmacia (Asia) Ltd. as Senior Business Manager from June 1993 to April 2003, managing marketing strategies in the pharmaceuticals field.
This person is not in any teams
This person is not in any offices
AffaMed Therapeutics
AffaMed Therapeutics is a clinical stage therapeutic company focused on developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmic, neurological and psychiatric disorders for patients in Greater China and around the world. The leadership team of AffaMed Therapeutics has gained deep industry expertise and an extensive track record in high-quality discovery, clinical development, regulatory affairs, manufacturing, commercial operations, and business development at leading multi-national pharmaceutical companies in China and globally.